Reata Pharmaceuticals Inc
NASDAQ:RETA
Income Statement
Earnings Waterfall
Reata Pharmaceuticals Inc
Revenue
|
23.5m
USD
|
Cost of Revenue
|
-1.6m
USD
|
Gross Profit
|
21.9m
USD
|
Operating Expenses
|
-363.6m
USD
|
Operating Income
|
-341.7m
USD
|
Other Expenses
|
254m
USD
|
Net Income
|
-87.6m
USD
|
Income Statement
Reata Pharmaceuticals Inc
Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||
Revenue |
51
N/A
|
51
-1%
|
50
0%
|
50
-1%
|
50
+0%
|
50
+0%
|
50
0%
|
50
+1%
|
51
+1%
|
51
+0%
|
48
-5%
|
68
+41%
|
62
-8%
|
55
-12%
|
54
-3%
|
29
-46%
|
29
+1%
|
32
+10%
|
27
-18%
|
20
-24%
|
15
-24%
|
8
-45%
|
9
+6%
|
9
-5%
|
8
-10%
|
14
+77%
|
11
-16%
|
11
0%
|
10
-13%
|
3
-69%
|
2
-30%
|
1
-32%
|
23
+1 469%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(124)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(98)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
22
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||
Operating Expenses |
(51)
|
(51)
|
(51)
|
(51)
|
(52)
|
(53)
|
(57)
|
(64)
|
(74)
|
(85)
|
(95)
|
(103)
|
(113)
|
(124)
|
(130)
|
(140)
|
(146)
|
(158)
|
(187)
|
(344)
|
(356)
|
(365)
|
(235)
|
(232)
|
(231)
|
(241)
|
(256)
|
(265)
|
(268)
|
(273)
|
(280)
|
(324)
|
(364)
|
|
Selling, General & Administrative |
(12)
|
(13)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(19)
|
(20)
|
(22)
|
(23)
|
(25)
|
(29)
|
(31)
|
(33)
|
(36)
|
(37)
|
(44)
|
(58)
|
(69)
|
(74)
|
(78)
|
(75)
|
(75)
|
(80)
|
(88)
|
(99)
|
(103)
|
(106)
|
(108)
|
(109)
|
(139)
|
(160)
|
|
Research & Development |
(36)
|
(36)
|
(35)
|
(36)
|
(35)
|
(36)
|
(39)
|
(45)
|
(54)
|
(63)
|
(71)
|
(78)
|
(84)
|
(92)
|
(97)
|
(102)
|
(108)
|
(113)
|
(128)
|
(150)
|
(157)
|
(162)
|
(159)
|
(146)
|
(150)
|
(152)
|
(156)
|
(161)
|
(160)
|
(164)
|
(170)
|
(186)
|
(203)
|
|
Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(124)
|
(124)
|
(124)
|
0
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
Operating Income |
(0)
N/A
|
(1)
-1 175%
|
(0)
+35%
|
(2)
-370%
|
(2)
-14%
|
(3)
-82%
|
(7)
-114%
|
(14)
-101%
|
(24)
-71%
|
(35)
-47%
|
(47)
-35%
|
(35)
+24%
|
(51)
-44%
|
(68)
-34%
|
(77)
-12%
|
(111)
-44%
|
(117)
-5%
|
(126)
-8%
|
(285)
-127%
|
(324)
-14%
|
(341)
-5%
|
(357)
-5%
|
(226)
+37%
|
(224)
+1%
|
(223)
+0%
|
(227)
-2%
|
(245)
-8%
|
(254)
-4%
|
(258)
-2%
|
(270)
-5%
|
(278)
-3%
|
(322)
-16%
|
(342)
-6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(8)
|
(13)
|
(13)
|
(12)
|
(10)
|
(7)
|
(7)
|
(6)
|
(5)
|
(2)
|
2
|
6
|
9
|
11
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(12)
|
(10)
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
2
|
0
|
280
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(9)
|
(22)
|
(33)
|
(44)
|
(47)
|
(47)
|
(46)
|
(45)
|
(43)
|
(42)
|
(41)
|
(38)
|
|
Pre-Tax Income |
0
N/A
|
(0)
N/A
|
(0)
+38%
|
(2)
-403%
|
(2)
-13%
|
(3)
-82%
|
(7)
-116%
|
(14)
-103%
|
(24)
-75%
|
(35)
-48%
|
(48)
-36%
|
(37)
+23%
|
(53)
-46%
|
(72)
-35%
|
(81)
-12%
|
(114)
-41%
|
(120)
-5%
|
(129)
-7%
|
(290)
-125%
|
(332)
-14%
|
(365)
-10%
|
(391)
-7%
|
(270)
+31%
|
(267)
+1%
|
(272)
-2%
|
(279)
-2%
|
(298)
-7%
|
(304)
-2%
|
(304)
0%
|
(312)
-2%
|
(312)
0%
|
(354)
-14%
|
(88)
+75%
|
|
Net Income | ||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
1
|
(1)
|
(2)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(0)
|
0
|
(1)
|
(3)
|
(2)
|
(4)
|
(6)
|
(13)
|
(24)
|
(35)
|
(48)
|
(37)
|
(53)
|
(72)
|
(81)
|
(114)
|
(120)
|
(129)
|
(290)
|
(332)
|
(365)
|
(391)
|
(270)
|
(266)
|
(272)
|
(278)
|
(297)
|
(304)
|
(305)
|
(312)
|
(312)
|
(354)
|
(88)
|
|
Net Income (Common) |
(0)
N/A
|
0
N/A
|
(1)
N/A
|
(3)
-112%
|
(2)
+25%
|
(4)
-66%
|
(6)
-62%
|
(13)
-110%
|
(24)
-81%
|
(35)
-48%
|
(48)
-36%
|
(37)
+23%
|
(53)
-46%
|
(72)
-35%
|
(81)
-12%
|
(114)
-41%
|
(120)
-5%
|
(129)
-7%
|
(290)
-125%
|
(310)
-7%
|
(343)
-11%
|
(369)
-8%
|
(248)
+33%
|
(266)
-7%
|
(271)
-2%
|
(278)
-2%
|
(297)
-7%
|
(304)
-2%
|
(305)
0%
|
(312)
-2%
|
(312)
0%
|
(354)
-14%
|
(88)
+75%
|
|
EPS (Diluted) |
0
N/A
|
0.02
N/A
|
-0.07
N/A
|
-0.15
-114%
|
-0.12
+20%
|
-0.19
-58%
|
-0.31
-63%
|
-0.6
-94%
|
-0.91
-52%
|
-1.41
-55%
|
-1.99
-41%
|
-1.37
+31%
|
-2.02
-47%
|
-2.49
-23%
|
-2.91
-17%
|
-3.81
-31%
|
-3.98
-4%
|
-4.27
-7%
|
-9.54
-123%
|
-9.33
+2%
|
-10.31
-11%
|
-10.94
-6%
|
-7.34
+33%
|
-7.35
0%
|
-7.47
-2%
|
-7.63
-2%
|
-8.19
-7%
|
-8.35
-2%
|
-8.37
0%
|
-8.53
-2%
|
-8.54
0%
|
-9.58
-12%
|
-2.11
+78%
|